Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?

Alimentary Pharmacology and Therapeutics · Published 2026-08-03 · DOI 10.1111/apt.70893

Free full text

Authors (3)

Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Guilherme Grossi Lopes Cançado

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Passos, P., Filho, V., Cançado, G. (2026). Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70893

Related articles

• Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis · Annals of Hepatology · 2026 · Cites or is cited by this article
• Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis · Liver International · 2022 · Cites or is cited by this article
• Management of autoimmune hepatitis-related decompensated cirrhosis: current evidence and clinical decision-making · Current Opinion in Gastroenterology · 2026 · Cites or is cited by this article
• Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Letter: External Validation of Hepcidin Thresholds for Predicting Response to Iron Therapy in Active Inflammatory Bowel Disease · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? · Alimentary Pharmacology and Therapeutics · 2026 · Same journal
• Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients · Alimentary Pharmacology and Therapeutics · 2026 · Same journal